Enrofloxacin is a fluorquinolone exclusively developed for use in veterinary medicine
(1980). The kinetics of enrofloxacin are characterized, in general terms, by high …

Antibiotics-based therapy plays a paramount role in equine medicine because of their
potential pharmacokinetics and pharmacodynamics properties. Conventional antibiotics …

Use of antimicrobial drugs is central to the treatment of primary and secondary bacterial
infection in horses. When selecting an antimicrobial to treat confirmed or suspected bacterial …

Antibiotics frequently play an important central or adjunctive role in the therapeutic
management of horses and foals with a variety of illnesses, including those requiring critical …

Pharmacokinetic behaviour of enrofloxacin was studied in 6 horses after intravenous (iv) or
intramuscular (im) administration of enrofloxacin (5 mg/kg bwt). Concentrations of …

Enrofloxacin is a broad-spectrum antimicrobial agent, but the study of its pharmacokinetics/
pharmacodynamics (PKs/PDs) in donkeys is rarely reported. The present study aimed to …

The pharmacokinetic behaviour of marbofloxacin, a new fluoroquinolone antimicrobial agent
developed exclusively for veterinary use, was studied in mature horses (n= 5) after single …

La enrofloxacina es un fluorquinolona desarrollada exclusivamente para ser usada en
medicina veterinaria. Se caracteriza por una muy buena actividad antimicrobiana, incluso …

Marbofloxacin is a fluoroquinolone antibiotic expected to be effective in the treatment of
infections involving Gram‐negative and some Gram‐positive bacteria in horses. In order to …

Objective—To evaluate clinical safety of administration of injectable enrofloxacin. Design—
Randomized controlled clinical trial. Animals—24 adult horses. Procedures—Healthy horses …